Oncology
ALIPEMETINIB – Pemigatinib
Pemigatinib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in treatment areas related to fgfr2 fusion or rearrangement cholangiocarcinoma reference; other fgfr contexts require review and should be reviewed for the relevant market, documentation, and intended business context. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.
Get a Quote
For wholesale, distribution, or sourcing inquiries, please contact our team.
Request Wholesale Quote Request Product Documents Contact Sales Team
Product availability, documentation, indications, and regulatory status vary by country or region. Product information is intended for qualified business partners only.

